Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2026-05-26 @ 7:09 AM
Study NCT ID:
NCT05430360
Status:
RECRUITING
Last Update Posted:
2025-02-17
First Post:
2022-06-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for the Treatment of Metastatic/recurrent Advanced Solid Tumors
Sponsor:
Grit Biotechnology
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GRIT-CO-FA-018
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None